Global patterns and trends in colorectal cancer incidence and mortality
- PMID: 26818619
- DOI: 10.1136/gutjnl-2015-310912
Global patterns and trends in colorectal cancer incidence and mortality
Abstract
Objective: The global burden of colorectal cancer (CRC) is expected to increase by 60% to more than 2.2 million new cases and 1.1 million deaths by 2030. In this study, we aim to describe the recent CRC incidence and mortality patterns and trends linking the findings to the prospects of reducing the burden through cancer prevention and care.
Design: Estimates of sex-specific CRC incidence and mortality rates in 2012 were extracted from the GLOBOCAN database. Temporal patterns were assessed for 37 countries using data from Cancer Incidence in Five Continents (CI5) volumes I-X and the WHO mortality database. Trends were assessed via the annual percentage change using joinpoint regression and discussed in relation to human development levels.
Results: CRC incidence and mortality rates vary up to 10-fold worldwide, with distinct gradients across human development levels, pointing towards widening disparities and an increasing burden in countries in transition. Generally, CRC incidence and mortality rates are still rising rapidly in many low-income and middle-income countries; stabilising or decreasing trends tend to be seen in highly developed countries where rates remain among the highest in the world.
Conclusions: Patterns and trends in CRC incidence and mortality correlate with present human development levels and their incremental changes might reflect the adoption of more western lifestyles. Targeted resource-dependent interventions, including primary prevention in low-income, supplemented with early detection in high-income settings, are needed to reduce the number of patients with CRC in future decades.
Keywords: COLORECTAL CANCER; EPIDEMIOLOGY.
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
Similar articles
-
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4. CA Cancer J Clin. 2021. PMID: 33538338
-
International variations and trends in testicular cancer incidence and mortality.Eur Urol. 2014 Jun;65(6):1095-106. doi: 10.1016/j.eururo.2013.11.004. Epub 2013 Nov 14. Eur Urol. 2014. PMID: 24268506
-
International variations in bladder cancer incidence and mortality.Eur Urol. 2014 Jul;66(1):59-73. doi: 10.1016/j.eururo.2013.10.001. Epub 2013 Oct 16. Eur Urol. 2014. PMID: 24451595
-
International variations and trends in renal cell carcinoma incidence and mortality.Eur Urol. 2015 Mar;67(3):519-30. doi: 10.1016/j.eururo.2014.10.002. Epub 2014 Oct 16. Eur Urol. 2015. PMID: 25449206 Review.
-
Worldwide variations in colorectal cancer.CA Cancer J Clin. 2009 Nov-Dec;59(6):366-78. doi: 10.3322/caac.20038. CA Cancer J Clin. 2009. PMID: 19897840 Review.
Cited by
-
Construction and validation of an immune-related gene signature predictive of survival and response to immunotherapy for colorectal cancer.Medicine (Baltimore). 2024 Oct 4;103(40):e39798. doi: 10.1097/MD.0000000000039798. Medicine (Baltimore). 2024. PMID: 39465758 Free PMC article.
-
The clinical features, management, and survival of elderly patients with colorectal cancer.J Gastrointest Oncol. 2021 Feb;12(1):89-99. doi: 10.21037/jgo-21-63. J Gastrointest Oncol. 2021. PMID: 33708427 Free PMC article.
-
Sequence Polymorphism in Xenobiotic Metabolising Genes in Iraqi Colorectal Cancer Patients.Asian Pac J Cancer Prev. 2021 Apr 1;22(4):1203-1210. doi: 10.31557/APJCP.2021.22.4.1203. Asian Pac J Cancer Prev. 2021. PMID: 33906313 Free PMC article.
-
[18F]-C-SNAT4: an improved caspase-3-sensitive nanoaggregation PET tracer for imaging of tumor responses to chemo- and immunotherapies.Eur J Nucl Med Mol Imaging. 2021 Oct;48(11):3386-3399. doi: 10.1007/s00259-021-05297-0. Epub 2021 Mar 13. Eur J Nucl Med Mol Imaging. 2021. PMID: 33712870
-
Germline RAD54L with somatic POLE defect implicated in Hypermutation phenotype: case report.BMC Gastroenterol. 2020 Aug 5;20(1):255. doi: 10.1186/s12876-020-01403-y. BMC Gastroenterol. 2020. PMID: 32758138 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical